UPC AI Analysis Overview
Keys for Bullish View
- Value≥4
- Dividend≥2
Analysis Conclusion
With insufficient quarterly financial data released by the company, we're unable to provide a rating.
UPC Current Performance
4.47%
Universe pharmaceuticals inc
1.19%
Avg of Sector
1.11%
S&P500
Top 10 High Relevance to UPC
| Symbol | Company Name | Value | Trend | Swing Trading | Whale Interest | Dividend | Add to Watchlist |
|---|---|---|---|---|---|---|---|
URGN | Urogen pharma ltd | 3 | 4 | 3 | 3 | 1 | |
ARMP | Armata pharmaceuticals inc | 1 | 3 | 2 | 1 | 1 | |
AVBP | Arrivent biopharma inc | - | 4 | 3 | 3 | 1 | |
EOLS | Evolus inc | 2 | 3 | 4 | 3 | 1 | |
BLTE | Belite bio inc - adr | - | 5 | 3 | 1 | 1 |
- URGN Urogen pharma ltdValue 3Trend 4Swing Trading 3Whale Interest 3Dividend 1See more
UPC Profile
Universe Pharmaceuticals Inc. Universe Pharmaceuticals Inc is a China-based holding company mainly engaged in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives (TCMD) products targeting the elderly. Through its subsidiary, the Company sells TCMD products, biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces (TCMPs), and dietary supplements manufactured by third-party pharmaceutical companies. Its TCMD products fall into two categories: chronic condition treatments as well as cold and flu medications, including Guben Yanling Pill, Shenrong Weisheng Pill, Fengshitong Medicinal Liquor, Isatis Root Granule and Qiangli Pipa Syrup. Its major customers are pharmaceutical companies, hospitals, clinics and drugstore chains. The Company mainly conducts its businesses within the Chinese market.